O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2020ACC: 0001209191-20-033456
Officer· Chief Medical Officer
Since Jun 2018
+68.00
Net shares
Net buyer
$944.18
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
68.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.00
Price / share
$27.77
Trade value
$944.18
% of position
1.7%
5/29/2020
1.99K→2.02K
Total
Net shares
+34.00
Net value
$944.18
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2020 | A · Award | +34.00 | $27.77 | $944.18 | 1.7% | 1.99K | 2.02K |
| Total | +34.00 | $944.18 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
34.00 shares
Shares
+34.00
Strike price
32.67
Held after
34.00
Exercisable
—
5/29/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock34.00 shares | 5/29/2020 | A · Award | +34.00 | 32.67 | — | 34.00 |